Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HVQ4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 138 | 142 | PF00656 | 0.662 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.495 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.516 |
CLV_PCSK_PC1ET2_1 | 6 | 8 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.340 |
DEG_APCC_DBOX_1 | 60 | 68 | PF00400 | 0.340 |
DOC_MAPK_gen_1 | 95 | 105 | PF00069 | 0.307 |
DOC_MAPK_MEF2A_6 | 98 | 106 | PF00069 | 0.351 |
DOC_PP2B_LxvP_1 | 29 | 32 | PF13499 | 0.679 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.682 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.616 |
DOC_USP7_UBL2_3 | 133 | 137 | PF12436 | 0.665 |
LIG_deltaCOP1_diTrp_1 | 91 | 99 | PF00928 | 0.462 |
LIG_LIR_LC3C_4 | 26 | 31 | PF02991 | 0.640 |
LIG_PDZ_Class_3 | 187 | 192 | PF00595 | 0.706 |
LIG_Pex14_1 | 93 | 97 | PF04695 | 0.463 |
LIG_SH2_CRK | 65 | 69 | PF00017 | 0.362 |
LIG_SH2_STAT3 | 57 | 60 | PF00017 | 0.603 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.701 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.589 |
LIG_SUMO_SIM_anti_2 | 26 | 32 | PF11976 | 0.683 |
LIG_SUMO_SIM_anti_2 | 47 | 53 | PF11976 | 0.627 |
LIG_SUMO_SIM_par_1 | 101 | 108 | PF11976 | 0.516 |
LIG_TRAF2_1 | 164 | 167 | PF00917 | 0.720 |
LIG_Vh1_VBS_1 | 103 | 121 | PF01044 | 0.299 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.731 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.648 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.772 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.744 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.485 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.705 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.721 |
MOD_N-GLC_1 | 186 | 191 | PF02516 | 0.460 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.642 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.507 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.435 |
MOD_PKA_1 | 135 | 141 | PF00069 | 0.675 |
MOD_PKA_2 | 135 | 141 | PF00069 | 0.707 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.743 |
MOD_Plk_1 | 46 | 52 | PF00069 | 0.630 |
MOD_Plk_1 | 89 | 95 | PF00069 | 0.431 |
MOD_Plk_2-3 | 169 | 175 | PF00069 | 0.686 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.349 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.630 |
TRG_NLS_MonoExtN_4 | 133 | 139 | PF00514 | 0.689 |
TRG_Pf-PMV_PEXEL_1 | 155 | 160 | PF00026 | 0.482 |
TRG_Pf-PMV_PEXEL_1 | 76 | 81 | PF00026 | 0.651 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8II27 | Leishmania donovani | 99% | 100% |
A4H7A9 | Leishmania braziliensis | 52% | 100% |
E9APF0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4QG28 | Leishmania major | 83% | 100% |